title: Linkage studies in erythrokeratodermias: fine mapping, genetic heterogeneity and analysis of candidate genes.
abstract: Erythrokeratodermias are a clinically heterogeneous group of rare autosomal dominant disorders of cornification with overlapping features including hyperkeratosis and erythema. We ascertained five extended pedigrees with different phenotypes for a linkage study. Three families presented with localized erythrokeratodermia variabilis, and one with erythrokeratodermia and ataxia. Another family had Greither disease associated with variable hyperkeratotic plaques. Despite their phenotypic differences, both erythrokeratodermia variabilis and erythrokeratodermia with ataxia map to a common region in 1p34-p35. Multipoint linkage and haplotype analyses place erythrokeratodermia variabilis between the marker D1S496 and D1S186 with a maximum LOD score of 12.88. Our linkage results provide compelling evidence for genetic homogeneity among families of mixed European and French-Canadian origin. In contrast, results excluded Greither's disease from the established erythrokeratodermia variabilis gene region indicating genetic heterogeneity of erythrokeratodermias. Based on recombinations, two genes assigned to 1p34-p35 were excluded: cartilage matrix protein and avian myelocytosis viral oncogene. Connexin-37 (GJA4), a member of the connexin gene family, maps within the erythrokeratodermia variabilis region and is an attractive candidate gene. Direct sequencing of the coding region of GJA4 in four patients revealed several variations, including a novel polymorphism within the 5' cytoplasmic domain, but no pathogenic mutations were found, thus excluding Connexin-37 as a candidate. There is evidence, however, that other epidermally expressed connexins cluster in this region, and one may yet be determined to play a role in the pathogenesis of erythrokeratodermia variabilis.
authors.affiliation: Genetic Studies Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: G
authors.initials: G
authors.lastname: Richard
authors.forename: J P
authors.initials: JP
authors.lastname: Lin
authors.forename: L
authors.initials: L
authors.lastname: Smith
authors.forename: Y M
authors.initials: YM
authors.lastname: Whyte
authors.forename: P
authors.initials: P
authors.lastname: Itin
authors.forename: U
authors.initials: U
authors.lastname: Wollina
authors.forename: E
authors.initials: E
authors.lastname: Epstein
authors.forename: D
authors.initials: D
authors.lastname: Hohl
authors.forename: J M
authors.initials: JM
authors.lastname: Giroux
authors.forename: L
authors.initials: L
authors.lastname: Charnas
authors.forename: S J
authors.initials: SJ
authors.lastname: Bale
authors.forename: J J
authors.initials: JJ
authors.lastname: DiGiovanna
mesh_terms: D002874:Chromosome Mapping; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics; D017630:Connexins / Q000235:genetics; D004890:Erythema / Q000235:genetics*; D005796:Genes / Q000235:genetics; D018740:Genetic Heterogeneity; D008040:Genetic Linkage; D006239:Haplotypes; D006801:Humans; D017495:Hyperpigmentation / Q000235:genetics*; D007642:Keratosis / Q000235:genetics*; D010375:Pedigree; D010641:Phenotype; D000097006:Gap Junction alpha-4 Protein
chemical_list: D017630:Connexins; D000097006:Gap Junction alpha-4 Protein